- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Early-Life Exposures Linked to Increased Risk of Juvenile Idiopathic Arthritis
Antibiotics and infections appear to be stronger markers of JIA risk than the antibiotics themselves
Apr. 2, 2026 at 10:23am
Got story updates? Submit your updates here. ›
New research indicates that while early-life antibiotic exposure is associated with an increased risk of a subsequent juvenile idiopathic arthritis (JIA) diagnosis, the relationship appears to be even stronger with exposure to nonbacterial antimicrobials or infections in general. The findings suggest the increased risk may be due to underlying immune dysfunction or infections triggering the disease, rather than a direct causal link with antibiotics.
Why it matters
Understanding the relationship between early-life exposures and JIA risk could help identify potential prevention strategies and improve our understanding of the complex interplay between the immune system, infections, and the development of autoimmune conditions like JIA.
The details
Researchers used large insurance databases to conduct a nested case-control study, identifying 5,175 cases of children aged 1-17 who received a new JIA diagnosis and 44,309 matched controls. They found that antibiotic exposure in the 10 months prior to the index date was associated with a 24% higher likelihood of a JIA diagnosis, with the risk increasing with the number of antibiotic courses. However, the association was even stronger for exposure to nonbacterial antimicrobials like antivirals and antifungals, as well as for any infection, suggesting the infections themselves or underlying immune dysfunction may be the more important factor.
- The study used data from 2001 to 2018 in a public insurance database and 2006 to 2023 in a commercial database.
The players
Daniel Horton, MD
An associate professor of pediatrics at Rutgers Robert Wood Johnson Medical School in New Brunswick, New Jersey, who led the research.
Randy Cron, MD, PhD
A professor of medicine and director of pediatric rheumatology at The University of Alabama Heersink School of Medicine in Birmingham, Alabama, who commented on the findings.
What they’re saying
“While we found dose- and time-dependent associations between antibiotic exposure and subsequent JIA diagnoses, we concluded that this seemed most likely to be markers of risk of infections before JIA diagnosis, either due to underlying, preceding immune dysfunction or infections that triggered subsequent disease.”
— Daniel Horton, Associate Professor of Pediatrics
“What's unclear is, is it the infection, or is it the host immune response that makes you more susceptible to infection that puts you at risk for developing JIA?”
— Randy Cron, Professor of Medicine, Director of Pediatric Rheumatology
What’s next
Researchers plan to further investigate whether the increased JIA risk is more closely linked to the infections themselves or to underlying immune dysfunction that makes individuals more susceptible to infections.
The takeaway
This study highlights the complex relationship between early-life exposures, the immune system, and the development of autoimmune conditions like juvenile idiopathic arthritis. The findings suggest the need for a deeper understanding of how infections, antibiotics, and other factors may interact to influence JIA risk.


